| Document |
Document Title |
|
WO/2017/046535A1 |
The subject matter of the present invention is a compound characterized in that it has the general formula (I): in which P1, X, n, A, L and L1 are as defined in Claim 1. The present invention also relates to a process for preparing said ...
|
|
WO/2017/043703A1 |
The present invention relates to a mannitol-based amphipathic compound, a method for preparing the same, a method of extraction, solubilization, stabilization or crystallization of a membrane protein using the same, and a method for anal...
|
|
WO/2017/037719A1 |
Novel aminoglycosides, represented by Formulae la and lb, as defined in the instant specification, designed to exhibit stop codon mutation readthrough activity, are provided. Also provided are pharmaceutical compositions containing the s...
|
|
WO/2017/037718A1 |
Novel pseudo-trisaccharide aminoglycosides, represented by Formula I, as defined in the instant specification, designed to exhibit stop codon mutation readthrough activity, are provided. Also provided are pharmaceutical compositions cont...
|
|
WO/2017/039107A1 |
The present invention relates to a xylene-based amphipathic compound, a method for preparing same, and a method for extracting, solubilizing, stabilizing, or crystallizing membrane proteins by using said compound. By using the xylene-bas...
|
|
WO/2017/037717A1 |
Novel pseudo-disaccharide and pseudo-trisaccharide aminoglycosides, represented by Formulae I or Ia, as defined in the instant specification, designed to exhibit stop codon mutation readthrough activity, are provided. Also provided are p...
|
|
WO/2017/027968A1 |
Adjuvants which rescue antibiotics against multidrug-resistant (MDR) organisms are a promising combination strategy to overcome bacterial resistance. While the combination of β-lactam β-lactamase inhibitor antibiotic has been successfu...
|
|
WO/2017/031189A1 |
The invention provides compositions and methods for the production of TDP-deoxysugars.
|
|
WO/2017/021385A1 |
The invention comprises a new process for the preparation of GalNAc derivatives of the formula I wherein n is an integer between 0 and 10 and its salts, corresponding enantiomers and/ or optical isomers thereof. The GalNAc acid derivativ...
|
|
WO/2017/017509A1 |
The present invention relates to novel oligomers of Neisseria meningitidis serogroup Y capsular polysaccharide repeating unit (Men-Y oligomers) and process for synthesizing novel Men- Y oligomers. In particular, the present invention rel...
|
|
WO/2017/019599A1 |
A process for the extraction and concentration of saponins from agricultural feedstocks. An agricultural feedstock can undergo a first preparation step intended to increase surface area of the feedstock for increased efficiency in extrac...
|
|
WO/2017/018528A1 |
Disclosed are: a compound represented by general formula (I), or a pharmaceutically acceptable salt of the compound, or a solvate of the compound or the pharmaceutically acceptable salt; a pharmaceutical composition containing the compou...
|
|
WO/2017/012289A1 |
Disclosed are compounds which can act as a positive allosteric modulator for erythropoietin and erythropoietin receptor and have the activity in promoting erythropoiesis. Also disclosed are pharmaceutical compositions comprising said com...
|
|
WO/2017/012572A1 |
Provided are crystalline form A of rebaudioside D, and a preparation method and application therefor. In X-ray powder diffraction analysis measured using Cu-Kα rays and with 2θ being expressed in degrees, crystalline form A of rebaudio...
|
|
WO/2017/007346A1 |
The present invention relates to novel derivatives of polyphenol glycoside or polyalcohols of formula (1), wherein R1, R2, R3 is selected from the group consisting of H, OH, C(O)R4, C(0) OR4, 0 (Gly H3)n, wherein n = 0 1, 2, 3, and R4 is...
|
|
WO/2016/202310A1 |
A sulphonated pentasaccharide compound having anti-Xa factor activity, and a preparation method and use for said compound. The compound is a derivative of a pentasaccharide compound having an anticoagulation effect, and has significant a...
|
|
WO/2016/198170A1 |
The present invention relates to well-defined synthetic saccharides of general formula (I) that are related to the repeating unit of Streptococcus pneumoniae serotype 5 capsular polysaccharide and conjugates thereof. The conjugates and p...
|
|
WO/2016/196927A1 |
Methods of using and pharmaceutical compositions comprising (2R,3S,4R,5R,6S)-5- amino-6-(((lR,2S,3S,4R,6S)-4,6-diamino-3-(((2R,3R,4R,5R)-3,5
-dihydroxy-5-methyl-4-(methylamino)tetrahydro-2H-pyran-2-yl)
oxy)-2-hydroxycyclohexyl)oxy)-2- (h...
|
|
WO/2016/189179A1 |
The invention relates to a compound of general formula (I), and to the use thereof in medicine, or for the production of a medicine for the treatment of different diseases, preferably a cancer such as melanoma, lung carcinoma or breast c...
|
|
WO/2016/188381A1 |
The present invention relates to the technical field of medical compounds, and relates to an oxidized β-1,4-oligoglucuronic acid, and a preparation method therefor and uses thereof. In the present invention, by using abundant cellulose ...
|
|
WO/2016/190383A1 |
A compound represented by structural formula (A) or (B); a method for producing the compound; a microorganism having an ability of producing the compound represented by the formula (A) or (B); and a compound-containing composition and an...
|
|
WO/2016/181013A1 |
The invention relates to the use of oligosaccharides as stimulators of plant growth in already germinated plants and to a method for obtaining said oligosaccharides. The invention particularly relates to the use of oligosaccharides compo...
|
|
WO/2016/180818A1 |
The present invention relates to glycosylating polyphenols via biocatalysis. More specifically the present invention discloses particular mutants of the thermostable sucrose phosphorylase derived from the microorganism Thermoanaerobacter...
|
|
WO/2016/180729A1 |
Apparatus and methods for reducing biofouling in drink such as beer dispensing equipment are described.
|
|
WO/2016/173425A1 |
This present invention relates to a glucopyranosyl derivative as sodium dependent glucose cotransporters (SGLTs) inhibitor, preparation processes thereof, and pharmaceutical uses thereof, pharmaceutical compositions containing the compou...
|
|
WO/2016/169288A1 |
The present invention relates to the field of pharmaceutical chemistry. Disclosed are a new amorphous piceatannol 3'-O-glucoside, preparation method thereof, and pharmaceutical composition containing the same. The amorphous piceatannol 3...
|
|
WO/2016/172615A1 |
The present invention provides N-acetyl-muramic acid (NAM) derivatives having Formula I, wherein Xa is selected from the group consisting of X1-X59, Ya is selected from the group consisting of H, monophosphate, uridine diphosphate and et...
|
|
WO/2016/164921A1 |
In various embodiments, the invention provides a radiotracer comprising a positron emitting atom bound to a deoxy sugar moiety. The radiotracer is reversible bound to a caging moiety that prevents or retards tissue uptake of the radiotra...
|
|
WO/2016/161951A1 |
A phillygenin glucuronic acid derivative represented by general formula (I). In general formula (I), R1=H, R2=CnH2n+1, and R3=CnH2n+1; or R1=CnH2n+1, R2=CnH2n+1, and R3=H; or R1-R2=-CH2-, and R3=CnH2n+1; n=1 to 30. The present invention ...
|
|
WO/2016/164394A1 |
Compounds, compositions, and methods for treatment and/or prevention of at least one disease, disorder, or condition by inhibiting binding of an E-selectin to an E-selectin ligand are disclosed, For example, E-selectin antagonist therape...
|
|
WO/2016/161377A1 |
This disclosure relates to the incorporation of amphiphilic guanidinylated aminoglycosides (e.g., neomycin) into liposomal assemblies, which contain entrapped therapeutics. The lysosome is responsible for enzymatically breaking down and ...
|
|
WO/2016/156338A1 |
The present invention relates to synthetic saccharides of general fornnula (I): V*−[Ux+2−Ux+ 1−Ux]n−V−O−L−NH2 that are related to carbapenem-resistant Kliebsella pneumoniae capsular polysaccharide and conjugates thereof. Sa...
|
|
WO/2016/159537A1 |
The present invention relates to a phytospingosine derivative generated by a condensation reaction of phytospingosine and maltose or lactose, which is an aldose-based disaccharide, and to a composition containing the same. The phytosping...
|
|
WO/2016/159092A1 |
In the present invention, an organic acid salt of 4'-epidaunorubicin or a hydrate or a solvate thereof is used as a novel production intermediate, whereby it is possible to efficiently remove 13-dihydroepidaunorubicin and 4'-epifeudomyci...
|
|
WO/2016/155888A1 |
The present invention relates to novel compounds of the formula I, methods for their preparation and their use for treatment of diseases. The invention discloses the synthesis of levodopa (L-DOPA) esters by coupling polyhydroxy compounds...
|
|
WO/2016/145997A1 |
Disclosed are a pharmaceutically active sugar molecule and a synthesis method thereof. The sugar molecule has a structure as shown by formula (I) or (II) and can be used for synthesizing a sulfonated sugar molecule, so that it can be fur...
|
|
WO/2016/145478A1 |
The present invention relates to novel compounds and their use in the prophylactic and/or therapeutic treatment of kidney and/or liver disease.
|
|
WO/2016/146941A1 |
The present invention relates to a new method for producing D-galacturonic derivatives and compositions having the formula (I) directly from pectins or pectin depolymerisation products, and to their use as surface active agents.
|
|
WO/2016/144175A1 |
The present invention relates generally to the production of steviol glycosides. Provided is a method for enzymatically providing a modified steviol glycoside, comprising incubating a steviol glycoside substrate in the presence of sucros...
|
|
WO/2016/143939A1 |
The present invention relates to a production method for a complex of a steviol glycoside and a sparingly soluble material having improved solubility, and to a complex of a steviol glycoside and a sparingly soluble material having improv...
|
|
WO/2016/142529A1 |
The present invention relates to a galactolipid having the following formula (I): (I) or compositions containing same, for use thereof in healing, in repair, reinforcement and re-equilibration of the skin barrier, in skin hydration and i...
|
|
WO/2016/145164A1 |
Provided herein are compounds, compositions, and methods having application in the field of enhanced oil recovery (EOR). In particular, the short hydrophobe anionic surfactants as well as aqueous compositions comprising these surfactants...
|
|
WO/2016/145192A1 |
Compositions and methods of utilizing the same are provided for treating bacterial infections. The compositions comprise acidified nitrite in combination with an iron chelator and an antibiotic. The compositions of the present invention ...
|
|
WO/2016/140355A1 |
The present invention provides a porous polymer compound having a three dimensional skeleton and pores and/or voids that are partitioned and formed by the three dimensional skeleton, said porous polymer compound being characterized in th...
|
|
WO/2016/141152A1 |
A rebaudioside D containing sweetening composition exhibiting taste like sugar containing a carrier and rebaudioside D is disclosed. A method of making the rebaudioside D containing sweetening composition; and a method of using the rebau...
|
|
WO/2016/134449A1 |
A Stevia rebaudiana plant is characterized by Rebaudioside A (RA) content of 6-20% dry weight and total steviol glycosides content of 15-28% dry weight in the leaf. The plant is developed using selective breeding technologies and identif...
|
|
WO/2016/120403A1 |
The present invention relates to a compound of the general formula (1). wherein the pyranose ring is a-D-galactopyranose, A is selected from The compound of formula (1) is suitable for use in a method for treating a disorder relating to ...
|
|
WO/2016/118932A1 |
The present disclosure relates to branched and linear chimeric compounds containing both nucleic acid and non-nucleic acid moieties, as well as to polynucleotides. The present disclosure also relates to uses thereof for stimulating an im...
|
|
WO/2016/116335A1 |
The present invention describes a process for the selective synthesis of N-Fmoc-doxorubicin-14-O-dicarboxylic acid mono ester derivatives starting from N-Fmoc-doxorubicin using lipase enzymes and bis-acyl donor compounds such as dicarbox...
|
|
WO/2016/115048A1 |
Provided are organic solvent free methods for obtaining compositions comprising one or more rhamnolipids as well as compositions obtainable from said methods.
|
